Reconciling the potentially irreconcilable? Genotypic and phenotypic amoxicillin-clavulanate resistance in Escherichia coli
Authors:
- Timothy J. DaviesTDTimothy J. Davies
- Nicole StoesserNSNicole Stoesser
- Anna E SheppardASAnna E Sheppard
- Manal AbuounMAManal Abuoun
- Philip W FowlerPFPhilip W Fowler
- Jeremy SwannJSJeremy Swann
- T. Phuong QuanTQT. Phuong Quan
- David GriffithsDGDavid Griffiths
- Alison VaughanAVAlison Vaughan
- Marcus MorganMMMarcus Morgan
- Hang T.T. PhanHPHang T.T. Phan
- Katie Jm JefferyKJKatie Jm Jeffery
Preprint
Abstract
Resistance to amoxicillin-clavulanate, a widely used beta-lactam/beta-lactamase inhibitor combination antibiotic, is rising globally, yet susceptibility testing remains challenging. To test whether whole-genome sequencing (WGS) could provide a more reliable assessment of susceptibility than traditional methods, we predicted resistance from WGS for 976 E. coli bloodstream infection isolates from Oxfordshire, UK, comparing against phenotypes from the BD Phoenix (calibrated against EUCAST guidelines). 339/976 (35%) isolates were amoxicillin-clavulanate resistant. Predictions based solely on beta-lactamase presence/absence performed poorly (sensitivity 23% (78/339)) but improved when genetic features associated with penicillinase hyper-production (e.g. promoter mutations, copy number estimates) were considered (sensitivity 82% (277/339); pE. coli is quantitative, rather than qualitative, explaining the poorly reproducible binary (resistant/susceptible) phenotypes and suboptimal concordance between different phenotypic methods and with WGS-based predictions.Keywords
All Related Versions
- Published version: Antimicrobial Agents and Chemotherapy, 64 (6).
This publication has 35 references indexed in Scilit:
- OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producingEscherichia coliJournal of Antimicrobial Chemotherapy, 2018
- Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients WithE coliorKlebsiella pneumoniaeBloodstream Infection and Ceftriaxone ResistanceJAMA, 2018
- Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health recordsThe Lancet Infectious Diseases, 2018
- Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131Genome Research, 2017
- The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST SubcommitteeClinical Microbiology and Infection, 2017
- A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogensInternational Journal of Antimicrobial Agents, 2015
- Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypesJournal of Antimicrobial Chemotherapy, 2015
- Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence dataJournal of Antimicrobial Chemotherapy, 2013
- Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2012
- Three Decades of β-Lactamase InhibitorsClinical Microbiology Reviews, 2010